EFDID: 227648EFD: View Filing

Issuer: Nacuity Pharmaceuticals, Inc. (0001690279) - D

Accession: 0001250853-16-000186 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001690279
  • Entity Name:
    Nacuity Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2016)
  • Address:
    FORT WORTH CLUB BLDG.
    306 W. 7TH STREET, SUITE 310
    FORT WORTH, TX 76102
  • Persons:
    Related Persons 1
    William Halden Conner
    Executive Officer, Director
EDGAR: Offering Information
  • Accession Date:
    12/08/2016
  • First Sale Date:
    11/08/2016
  • Offering Amount:
    $2,500,000
  • Amount Sold:
    $1,973,000
  • Amount Remaining:
    $527,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Nacuity Pharmaceuticals, Inc./s/ Halden ConnerHalden ConnerPresident2016-12-07